These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 9758259)
1. Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study. Riyazi N; Leeda M; de Vries JI; Huijgens PC; van Geijn HP; Dekker GA Eur J Obstet Gynecol Reprod Biol; 1998 Sep; 80(1):49-54. PubMed ID: 9758259 [TBL] [Abstract][Full Text] [Related]
2. Effect of thrombophylaxis on uterine and fetal circulation in pregnant women with a history of pregnancy complications. Bar J; Mashiah R; Cohen-Sacher B; Hod M; Orvieto R; Ben-Rafael Z; Lahav J Thromb Res; 2001 Feb; 101(4):235-41. PubMed ID: 11248284 [TBL] [Abstract][Full Text] [Related]
3. Effects of anticoagulant therapy on pregnancy outcomes in patients with thrombophilia and previous poor obstetric history. Mutlu I; Mutlu MF; Biri A; Bulut B; Erdem M; Erdem A Blood Coagul Fibrinolysis; 2015 Apr; 26(3):267-73. PubMed ID: 25268607 [TBL] [Abstract][Full Text] [Related]
4. Non-pregnant circulatory volume status predicts subsequent pregnancy outcome in normotensive thrombophilic formerly preeclamptic women. Spaanderman ME; Aardenburg R; Ekhart TH; van Eyndhoven HW; van der Heijden OW; van Eyck J; de Leeuw PW; Peeters LL Eur J Obstet Gynecol Reprod Biol; 2001 Apr; 95(2):218-21. PubMed ID: 11301175 [TBL] [Abstract][Full Text] [Related]
5. [Thrombophilia, preeclampsia and other pregnancy complications]. Vucić N; Frleta M; Petrović D; Ostojić V Acta Med Croatica; 2009 Oct; 63(4):297-305. PubMed ID: 20034330 [TBL] [Abstract][Full Text] [Related]
6. Low-molecular-weight heparin for the prevention of preeclampsia in high-risk pregnancies without thrombophilia: a systematic review and meta-analysis. Chen J; Huai J; Yang H BMC Pregnancy Childbirth; 2024 Jan; 24(1):68. PubMed ID: 38233773 [TBL] [Abstract][Full Text] [Related]
7. Does low-molecular-weight heparin influence fetal growth or uterine and umbilical arterial Doppler in women with a history of early-onset uteroplacental insufficiency and an inheritable thrombophilia? Secondary randomised controlled trial results. Abheiden C; Van Hoorn ME; Hague WM; Kostense PJ; van Pampus MG; de Vries J BJOG; 2016 Apr; 123(5):797-805. PubMed ID: 26036190 [TBL] [Abstract][Full Text] [Related]
8. Low-molecular-weight heparin plus aspirin versus aspirin alone in pregnant women with hereditary thrombophilia to improve live birth rate: meta-analysis of randomized controlled trials. Areia AL; Fonseca E; Areia M; Moura P Arch Gynecol Obstet; 2016 Jan; 293(1):81-86. PubMed ID: 26059084 [TBL] [Abstract][Full Text] [Related]
9. Outcomes in an obstetrical population with hereditary thrombophilia and high tobacco use. Calhoun B; Hoover E; Seybold D; Broce M; Hill A; Schaible B; Bracero LA J Matern Fetal Neonatal Med; 2018 May; 31(10):1267-1271. PubMed ID: 28367651 [TBL] [Abstract][Full Text] [Related]
10. Recurrence rate of pre-eclampsia in women with thrombophilia influenced by low-molecular-weight heparin treatment? Kalk JJ; Huisjes AJ; de Groot CJ; van Beek E; van Pampus MG; Spaanderman ME; van Eyck J; Oei SG; Bezemer PD; de Vries JI Neth J Med; 2004 Mar; 62(3):83-7. PubMed ID: 15209472 [TBL] [Abstract][Full Text] [Related]
11. [INDICATIONS FOR ANTITHROMBOTIC MEDICATION DURING PREGNANCY--ANALYSIS OF CURRENT PRACTICES IN BULGARIA]. Neikova K ; Dimitrova V; Dimitrov R; Savov A Akush Ginekol (Sofiia); 2015; 54(5):3-12. PubMed ID: 26411189 [TBL] [Abstract][Full Text] [Related]
12. Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT. de Vries JI; van Pampus MG; Hague WM; Bezemer PD; Joosten JH; J Thromb Haemost; 2012 Jan; 10(1):64-72. PubMed ID: 22118560 [TBL] [Abstract][Full Text] [Related]
13. Aspirin, low molecular weight heparin, or both in preventing pregnancy complications in women with recurrent pregnancy loss and factor V Leiden mutation. Karadağ C; Akar B; Gönenç G; Aslancan R; Yılmaz N; Çalışkan E J Matern Fetal Neonatal Med; 2020 Jun; 33(11):1934-1939. PubMed ID: 31550962 [No Abstract] [Full Text] [Related]
14. Low-molecular-weight heparin for prevention of preeclampsia and other placenta-mediated complications: a systematic review and meta-analysis. Cruz-Lemini M; Vázquez JC; Ullmo J; Llurba E Am J Obstet Gynecol; 2022 Feb; 226(2S):S1126-S1144.e17. PubMed ID: 34301348 [TBL] [Abstract][Full Text] [Related]
15. Low molecular weight heparin versus no treatment in women with previous severe pregnancy complications and placental findings without thrombophilia. Kupferminc M; Rimon E; Many A; Maslovitz S; Lessing JB; Gamzu R Blood Coagul Fibrinolysis; 2011 Mar; 22(2):123-6. PubMed ID: 21192252 [TBL] [Abstract][Full Text] [Related]
16. Low-molecular-weight heparin for thrombophilia in pregnant women. Bar J; Cohen-Sacher B; Hod M; Blickstein D; Lahav J; Merlob P Int J Gynaecol Obstet; 2000 Jun; 69(3):209-13. PubMed ID: 10854861 [TBL] [Abstract][Full Text] [Related]
17. Treatment of adverse perinatal outcome in inherited thrombophilias: a clinical study. Kosar A; Kasapoglu B; Kalyoncu S; Turan H; Balcik OS; Gümüs EI Blood Coagul Fibrinolysis; 2011 Jan; 22(1):14-8. PubMed ID: 21042205 [TBL] [Abstract][Full Text] [Related]
19. Prevention of pre-eclampsia by low-molecular-weight heparin in addition to aspirin: a meta-analysis. Roberge S; Demers S; Nicolaides KH; Bureau M; Côté S; Bujold E Ultrasound Obstet Gynecol; 2016 May; 47(5):548-53. PubMed ID: 26481090 [TBL] [Abstract][Full Text] [Related]
20. Dalteparin and low-dose aspirin in the prevention of adverse obstetric outcomes in women with inherited thrombophilia. Leduc L; Dubois E; Takser L; Rey E; David M J Obstet Gynaecol Can; 2007 Oct; 29(10):787-93. PubMed ID: 17915061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]